Bal Pharma Limited
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Bal Pharma Limited's balance sheet done over the years? Its assets were worth $3,195,255,000 last year, which is more than in the previous period. 78% of Bal Pharma Limited’s total assets is currently financed by debt. Its liabilities reached the amount of $2,502,641,000, which means an increase by 24% compared compared to last year.
Debt to Assets
| 2011 | 1353036799 | 991.28M | 73.26% |
|---|---|---|---|
| 2012 | 1411637556 | 1.01B | 71.62% |
| 2015 | 1638628397 | 1.08B | 66.33% |
| 2016 | 2110302952 | 1.56B | 74.07% |
| 2018 | 2518145000 | 1.91B | 76.09% |
| 2019 | 2613083000 | 2.01B | 76.95% |
| 2020 | 2383871000 | 1.93B | 80.98% |
| 2021 | 2400804000 | 1.86B | 77.78% |
| 2022 | 2605327000 | 2.02B | 77.55% |
| 2024 | 3195255000 | 2.50B | 78.32% |
BALPHARMA.NS Balance Sheet (2011 – 2023)
| 2023 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 41.95M | 11.12M | 10.23M | 8.58M | 24.36M | 27.08M | 46.34M | 54.94M | 30.26M | 22.30M |
Short term investments | 157.33M | 49.71M | 29.47M | 26.47M | 17.09M | 13.31M | -3.19M | -2.93M | 0 | 0 |
Net receivables | 996.21M | 1.03B | 994.77M | 899.81M | 954.39M | 640.46M | 591.40M | 449.84M | 0 | 0 |
Inventory | 878.11M | 743.95M | 603.85M | 677.11M | 697.51M | 664.93M | 417.54M | 358.15M | 336.59M | 322.14M |
Other current assets | 267.84M | 4.42M | 3.13M | -699K | 125.70M | 501.90M | 396.65M | 188.30M | 478.10M | 464.55M |
Total current assets | 2.34B | 1.84B | 1.64B | 1.61B | 1.81B | 1.75B | 1.42B | 1.05B | 844.97M | 809.00M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 642.54M | 572.75M | 575.08M | 637.69M | 644.77M | 634.13M | 555.28M | 480.91M | 476.65M | 484.44M |
Goodwill | 38.28M | 38.28M | 38.28M | 38.28M | 38.28M | 29.02M | 0 | 48.24M | 0 | 0 |
Intangible assets | 113.81M | 83.01M | 72.48M | 64.28M | 57.11M | 44.73M | 46.28M | 485.55K | 0 | 0 |
Long term investments | 3.97M | -43.93M | -21.41M | 10.19M | 7.88M | -8.01M | 3.34M | 3.08M | 0 | 0 |
Other non-current assets | 31.04M | 90.76M | 43.27M | 1K | 53.83M | -246K | 65.31M | 57.73M | 90.01M | 150K |
Total non-current assets | 853.78M | 759.62M | 759.33M | 772.57M | 794.01M | 758.74M | 680.32M | 587.38M | 566.66M | 544.03M |
Total assets | 3.19B | 2.60B | 2.40B | 2.38B | 2.61B | 2.51B | 2.11B | 1.63B | 1.41B | 1.35B |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 192.03M | 112.32M | 193.77M | 119.35M | 129.69M | 22.39M | 18.28M | 0 | 0 |
Short term debt | 1.04B | 773.88M | 863.98M | 961.52M | 947.45M | 815.96M | 526.27M | 384.76M | 445.29M | 8.85M |
Total current liabilities | 2.03B | 1.65B | 1.52B | 1.59B | 1.63B | 1.45B | 1.11B | 923.58M | 863.18M | 345.87M |
| Non-current liabilities: | ||||||||||
Long term debt | 377.23M | 292.67M | 255.47M | 242.67M | 287.56M | 346.76M | 349.56M | 66.44M | 60.90M | 577.30M |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68.10M |
Other non-current liabilities | 55.37M | 46.93M | 40.65M | 36.13M | 27.12M | 41.64M | 31.80M | 80.40M | 12.80M | 0 |
Total non-current liabilities | 472.21M | 363.95M | 341.93M | 335.57M | 378.49M | 464.07M | 451.15M | 163.36M | 147.89M | 645.40M |
Total liabilities | 2.50B | 2.02B | 1.86B | 1.93B | 2.01B | 1.91B | 1.56B | 1.08B | 1.01B | 991.28M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |